On serotonin and migraine: a clinical and pharmacological review (Q28263827)

The platelet and the neuron: two cells in focus in migraine

Europe PubMed Central

title

On serotonin and migraine: a clinical and pharmacological review (English)

0 references

0 references

1 reference

1 reference

1

M D Ferrari

0 references

author name string

P R Saxena

series ordinal

2

0 references

language of work or name

English

0 references

publication date

June 1993

0 references

published in

Cephalalgia

0 references

volume

13

0 references

issue

3

0 references

page(s)

151-65

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Platelets as a model for neurones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Anatomical features and physiological properties of central serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Structure and function of the brain serotonin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Neuronal 5-HT receptors in the periphery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Rationale for the use of 5-HT1-like agonists in the treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-HT1-like receptor agonists and the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Cerebral circulatory and metabolic effects of 5-hydroxytryptamine in anesthetized baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The effects of serotonin on local cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetized cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Central serotonergic nerves project to the pial vessels of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Serotonergic innervation of cat cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Platelet serotonin (5-HT) and 5-HT releasing factor in plasma of migrainous patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Platelet met-enkephalin immunoreactivity and 5-hydroxytryptamine concentrations in migraine patients: effects of 5-hydroxytryptophan, amitriptyline and chlorimipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Met-enkephalin immunoreactivity in blood platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Kinetics of platelet 5-hydroxytryptamine uptake in headache patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Distinct monoamine oxidase A and B populations in primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Transitory decrease in platelet monoamine-oxidase activity during migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The effects of reserpine injection on methysergide treated control and migrainous subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Severe headache and disturbed liver function during treatment with zimelidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-HT1C receptor activation: a key step in the initiation of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Serotonin-releasing effects of substituted piperazines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Clinical pharmacokinetics of ergotamine in migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Ergotamine dependency--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The treatment of cluster headache with repetitive intravenous dihydroergotamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Arterial stenosis in migraine: spasm or arteriopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-HT3 receptor antagonists and migraine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

First Clinical Study of the Selective 5-HT3 Antagonist, Granisetron (BRL 43694), in the Acute Treatment of Migraine Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Antimigraine drug interactions with serotonin receptor subtypes in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Lack of antinociceptive activity of sumatriptan in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

21 January 2018

Serotonin and migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The safety and tolerability of sumatriptan: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Psychoactivity and abuse potential of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-HT receptors in human and animal cerebrovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Evidence for the presence of 5-HT1-like receptors in rabbit isolated basilar arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Cluster headache: evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Calcitonin gene-related peptide: functional role in cerebrovascular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Cerebral hyperemia during spontaneous cluster headaches with excessive cerebral vasoconstriction to hyperoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Identification of 5-hydroxytryptamine1D binding sites in human brain membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Antimigraine drug interactions with 5-hydroxytryptamine1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

5-Hydroxytryptamine and the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Cortical spreading depression as a putative migraine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Oral sumatriptan in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1303151.X

10.1046/J.1468-2982.1993.1303151.X

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

8395342

1 reference

Consolidated OpenCitations Corpus – April 2017